目的:探寻益气复脉/参芪扶正注射液发挥补气作用的潜在靶基因及其生物学功能。方法:利用高通量转录组测序技术,考察气虚患者经益气复脉/参芪扶正注射液治疗后,其外周血单核细胞的差异表达基因、GO(Gene Ontotology)分析及KEGG(Kyoto enc...目的:探寻益气复脉/参芪扶正注射液发挥补气作用的潜在靶基因及其生物学功能。方法:利用高通量转录组测序技术,考察气虚患者经益气复脉/参芪扶正注射液治疗后,其外周血单核细胞的差异表达基因、GO(Gene Ontotology)分析及KEGG(Kyoto encyclopedia of genes and genomes)分析,并进一步进行韦恩分析,明确2个制剂治疗后共同的差异基因及生物学功能,最后利用一组临床队列样本,通过实时定量PCR,验证并明确与补气密切相关的基因。结果:两组共有的GO条目,包括生物过程的有32条,细胞组分的有2条,分子功能的有6条,生物通路有10条。共表达差异基因有6个,包括DUSP1、DUSP2、FKBP5、F8A2、C9orf129 EGR1。临床队列样本显示,FKBP5的下调有统计学差异(P=0.001)。结论:MAPK信号通路是益气复脉和参芪扶正发挥补气作用的核心通路,FKBP5基因水平下调是它们发挥补气作用的分子标志。展开更多
OBJECTIVE: To systematically evaluate the efficacy and safety of blood pricking and cupping in the treatment of nonspecific low back pain(NLBP).METHODS:The China National Knowledge Infrastructure Database(CNKI), Wanfa...OBJECTIVE: To systematically evaluate the efficacy and safety of blood pricking and cupping in the treatment of nonspecific low back pain(NLBP).METHODS:The China National Knowledge Infrastructure Database(CNKI), Wanfang Med Online Database(Wanfang), China Science and Technology Journal Database(VIP), Pub Med, Web of Science,EMBase, and Cochrane Library databases were searched from inception to October 31, 2021, for randomized controlled trials(RCTs) of the treatment of NLBP by blood pricking and cupping. The quality of each included study was evaluated according to the Cochrane Systematic Assessor’s Manual evaluation criteria, while the Meta-analysis was performed using RevMan 5.4software.RESULTS: A total of 13 thirteen RCTs included a total of 1088 subjects. The visual analogue scale scores indicated that blood pricking and cupping was superior to the other treatments at relieving NLBP pain [mean difference(MD) =-1.43;95% confidence interval(CI):-2.31 to 0.54;Z = 3.15;P = 0.002). The Oswestry Disability Index score of blood pricking and cupping was superior to that of the control group in terms of improving NLBP dysfunction(MD =-6.25;95%CI:-8.37 to-4.31);Z = 5.77;P < 0.000 01). 7 RCTs mentioned no adverse reactions, while one study reported mild syncope [7%(n = 3), all in the 17-30 years group] that was gradually relieved after rest. CONCLUSIONS: Blood pricking and cupping therapy can safely and effectively reduce pain and improve functional impairment in patients with NLBP. However, this study included limited high-grade studies with a small overall sample size;therefore, further high-quality large-sample RCTs are needed to improve clinical evidence.展开更多
文摘目的:探寻益气复脉/参芪扶正注射液发挥补气作用的潜在靶基因及其生物学功能。方法:利用高通量转录组测序技术,考察气虚患者经益气复脉/参芪扶正注射液治疗后,其外周血单核细胞的差异表达基因、GO(Gene Ontotology)分析及KEGG(Kyoto encyclopedia of genes and genomes)分析,并进一步进行韦恩分析,明确2个制剂治疗后共同的差异基因及生物学功能,最后利用一组临床队列样本,通过实时定量PCR,验证并明确与补气密切相关的基因。结果:两组共有的GO条目,包括生物过程的有32条,细胞组分的有2条,分子功能的有6条,生物通路有10条。共表达差异基因有6个,包括DUSP1、DUSP2、FKBP5、F8A2、C9orf129 EGR1。临床队列样本显示,FKBP5的下调有统计学差异(P=0.001)。结论:MAPK信号通路是益气复脉和参芪扶正发挥补气作用的核心通路,FKBP5基因水平下调是它们发挥补气作用的分子标志。
基金Supported by the National Natural Science Foundation of China:Novel Dynamic Regulation Method of Acupoint Stimulation Based on Injectable Magnetic Gel for Myocardial Ischemia-Reperfusion Injury (No. 82074560)Effect Evaluation of Different Combinations of Acupuncture Techniques (No. 8207152951)the Shaanxi Province Innovation Capacity Support Program Project:Exploring the Mechanism of Moxibustion on Diarrheal Irritable Bowel Syndrome based on the"Intestinal Flora-Intestinal Mucosal Immunity"Pathway (No. 2020KJXX-075)。
文摘OBJECTIVE: To systematically evaluate the efficacy and safety of blood pricking and cupping in the treatment of nonspecific low back pain(NLBP).METHODS:The China National Knowledge Infrastructure Database(CNKI), Wanfang Med Online Database(Wanfang), China Science and Technology Journal Database(VIP), Pub Med, Web of Science,EMBase, and Cochrane Library databases were searched from inception to October 31, 2021, for randomized controlled trials(RCTs) of the treatment of NLBP by blood pricking and cupping. The quality of each included study was evaluated according to the Cochrane Systematic Assessor’s Manual evaluation criteria, while the Meta-analysis was performed using RevMan 5.4software.RESULTS: A total of 13 thirteen RCTs included a total of 1088 subjects. The visual analogue scale scores indicated that blood pricking and cupping was superior to the other treatments at relieving NLBP pain [mean difference(MD) =-1.43;95% confidence interval(CI):-2.31 to 0.54;Z = 3.15;P = 0.002). The Oswestry Disability Index score of blood pricking and cupping was superior to that of the control group in terms of improving NLBP dysfunction(MD =-6.25;95%CI:-8.37 to-4.31);Z = 5.77;P < 0.000 01). 7 RCTs mentioned no adverse reactions, while one study reported mild syncope [7%(n = 3), all in the 17-30 years group] that was gradually relieved after rest. CONCLUSIONS: Blood pricking and cupping therapy can safely and effectively reduce pain and improve functional impairment in patients with NLBP. However, this study included limited high-grade studies with a small overall sample size;therefore, further high-quality large-sample RCTs are needed to improve clinical evidence.
